SCHOONVAERE MEDICAL
SCHOONVAERE MEDICAL has been active since 2008 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €377k and a net result of €126k. The computed 12-month bankruptcy probability is 0.1% (very low).
| Equity | €377k |
| Net result | €126k |
| Active | 18 yrs |
| Board | 1 |
Strong profile, led by profitability.
Computed on 4 of 5 axes. Not measured: growth. An unmeasured axis is not a zero: no data was read for it.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.
See plans →| Fiscal year | 2025 |
|---|---|
| Deposit | micro schema |
| Revenue | - |
| EBITDA | - |
| Net profit | €126k |
| Cash flow | - |
| Staff costs | - |
| Income taxes | €55k |
| Dividends | €175k |
| Total assets | €585k |
| Equity | €377k |
| Debt | €208k |
| of which ≤ 1y | €208k |
| of which > 1y | - |
| Working capital | €377k |
| Employees (FTE) | - |
| 2025 | |
|---|---|
| Current ratio | 2.81 |
| Quick ratio | 2.81 |
| Working capital ratio | 64.4% |
| Solvency | 64.4% |
| Debt / equity | 0.55 |
| Long-term debt ratio | - |
| Interest coverage | - |
| Gross margin | - |
| Net margin | - |
| ROA | 21.5% |
| ROE | 33.4% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
Full annual accounts (23 line items)
| Line item | Code | 2025 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €585k |
| Fixed assets | 21/28 | €50 |
| Financial fixed assets | 28 | €50 |
| Current assets | 29/58 | €584k |
| Amounts receivable within one year | 40/41 | €13k |
| Investments | 50/53 | €163k |
| Cash & bank | 54/58 | €388k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €585k |
| Equity | 10/15 | €377k |
| Contributions / capital | 10/11 | €12k |
| Reserves | 13 | €364k |
| Accumulated profits (losses) | 14 | €309 |
| Amounts payable | 17/49 | €208k |
| Amounts payable within one year | 42/48 | €208k |
| Trade debts payable within one year | 44 | €11k |
| Income statement | ||
| Gross operating margin | 9900 | €179k |
| Operating result | 9901 | €177k |
| Financial income | 75 | €4k |
| Financial charges | 65 | €435 |
| Result before taxes | 9903 | €181k |
| Income taxes | 67/77 | €55k |
| Net result for the period | 9904 | €126k |
| Result to be appropriated | 9905 | €126k |
-
Benoît SCHOONVAEREDirectorState Gazette act 23454417 (12-12-2023)Current12-12-2023 → present
| NACE primary | Activiteiten van medische beeldvorming en medische laboratoria(86910) |
| Legal form | Private limited company(610) |
| Incorporation | 27-06-2008 |
| Status | Active |
| Postal code | 5020 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 92043G0206/00A000 | Wallonia | 1,083 m² | 1 · 61 m² | 10.9 m · 3 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
12-12-2023 Benoît SCHOONVAERE appointed as director
- Benoît SCHOONVAERE, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Beno\u00EEt SCHOONVAERE",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0898.861.683",
"name_full": "SCHOONVAERE MEDICAL"
}
}| Legal nameFR | SCHOONVAERE MEDICAL |